Publication:
Pain management & opioid dose reduction with topical sevoflurane instillations in intractable venous ulcers: a case report

dc.contributor.authorDamaso Fernandez-Gines, F.
dc.contributor.authorCortinas-Saenz, Manuel
dc.contributor.authorAgudo-Ponce, Desiree
dc.contributor.authorAntonio Morales-Molina, Jose
dc.contributor.authorFernandez Sanchez, Carmen
dc.contributor.authorSierra-Garcia, Francisco
dc.contributor.authoraffiliation[Damaso Fernandez-Gines, F.] Torrecardenas Univ Hosp, Pharm Dept, Hermanos Donantes de Sangre S-N, Almeria 04009, Spain
dc.contributor.authoraffiliation[Fernandez Sanchez, Carmen] Torrecardenas Univ Hosp, Pharm Dept, Hermanos Donantes de Sangre S-N, Almeria 04009, Spain
dc.contributor.authoraffiliation[Sierra-Garcia, Francisco] Torrecardenas Univ Hosp, Pharm Dept, Hermanos Donantes de Sangre S-N, Almeria 04009, Spain
dc.contributor.authoraffiliation[Cortinas-Saenz, Manuel] Torrecardenas Univ Hosp, Anesthesiol & Pain Management Dept, Almeria, Spain
dc.contributor.authoraffiliation[Agudo-Ponce, Desiree] Torrecardenas Univ Hosp, Anesthesiol & Pain Management Dept, Almeria, Spain
dc.contributor.authoraffiliation[Antonio Morales-Molina, Jose] Publ Hlth Agcy Poniente, Pharm Dept, El Ejido, Spain
dc.date.accessioned2023-05-03T13:37:14Z
dc.date.available2023-05-03T13:37:14Z
dc.date.issued2022-01-01
dc.description.abstractVascular ulcers (VU) constitute a major cause of pain and disability, and significantly compromise quality of life. VU have a natural tendency to become chronic and in many cases exhibit anunsatisfactoryresponse to many of the standard therapeutic options.The case of a 73 year-old Caucasian female with severe pain and poorly-controlled pain (Visual Analogic Scale-VAS- of 8-9) due to three lower leg long-standing VUs is reported and discussed herein. The patient was treated with topical instillations of undiluted sevoflurane as per institutional off-label protocol (starting doses of lmL/cm(2) twice a day, and up-titrated according to response to a maximum of 7 mL twice daily). The VAS score dropped to 0-1 shortly after initiation of therapy and remained stable throughout treatment up until the closure of the observations. Subsequently, opioid therapy was gradually tapered down and ultimately abandoned.Sevoflurane application resulted on adequate and sustained pain management of refractory VU, with no significant side effects. On account of its beneficial effectivity and safety profiles, topical sevoflurane emerges as an add-on alternative for the long-term management of VU, and potentially other painful conditions.
dc.identifier.doi10.1590/s2175-97902020000318681
dc.identifier.essn2175-9790
dc.identifier.issn1984-8250
dc.identifier.unpaywallURLhttps://www.scielo.br/j/bjps/a/mG58BmFXkfwcp4gGNXv9kYf/?lang=en&format=pdf
dc.identifier.urihttp://hdl.handle.net/10668/20451
dc.identifier.wosID760390000001
dc.journal.titleBrazilian journal of pharmaceutical sciences
dc.journal.titleabbreviationBraz. j. pharm. sci.
dc.language.isoen
dc.organizationHospital Torrecárdenas
dc.organizationHospital Torrecárdenas
dc.organizationAPES Hospital de Poniente de Almería
dc.publisherUniv sao paulo, conjunto quimicas
dc.rightsAttribution 4.0 International
dc.rights.accessRightsopen access
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/
dc.subjectPain, vascular ulcer
dc.subjectTopical drug administration
dc.subjectOpioids
dc.subjectSevoflurane
dc.titlePain management & opioid dose reduction with topical sevoflurane instillations in intractable venous ulcers: a case report
dc.typeresearch article
dc.type.hasVersionVoR
dc.volume.number58
dc.wostypeArticle
dspace.entity.typePublication

Files